These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. NPY and carbachol raise Ca2+ in SK-N-MC cells by three different mechanisms. Evidence for inositol phosphate-independent Ca2+ mobilization by NPY. Michel MC; Feth F; Stieneker M; Rascher W Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):370-4. PubMed ID: 1620239 [TBL] [Abstract][Full Text] [Related]
44. Intracellular signaling leads to the hypertrophic effect of neuropeptide Y. Goldberg Y; Taimor G; Piper HM; Schlüter KD Am J Physiol; 1998 Nov; 275(5):C1207-15. PubMed ID: 9814968 [TBL] [Abstract][Full Text] [Related]
45. Direct neuropeptide Y-induced modulation of gonadotrope intracellular calcium transients and gonadotropin secretion. Shangold GA; Miller RJ Endocrinology; 1990 May; 126(5):2336-42. PubMed ID: 2109684 [TBL] [Abstract][Full Text] [Related]
46. Hypothalamic paraventricular 5-hydroxytryptamine: receptor-specific inhibition of NPY-stimulated eating and energy metabolism. Currie PJ; Coiro CD; Niyomchai T; Lira A; Farahmand F Pharmacol Biochem Behav; 2002 Apr; 71(4):709-16. PubMed ID: 11888562 [TBL] [Abstract][Full Text] [Related]
47. Norepinephrine release and neuropeptide Y in medulla oblongata of spontaneously hypertensive rats. Tsuda K; Tsuda S; Masuyama Y; Goldstein M Hypertension; 1990 Jun; 15(6 Pt 2):784-90. PubMed ID: 1972138 [TBL] [Abstract][Full Text] [Related]
48. Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists. Kalra SP; Dube MG; Fournier A; Kalra PS Physiol Behav; 1991 Jul; 50(1):5-9. PubMed ID: 1658831 [TBL] [Abstract][Full Text] [Related]
49. Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel. Zheng J; Morrisett RA; Zhu J; Hexum TD J Pharmacol Exp Ther; 1995 Aug; 274(2):891-7. PubMed ID: 7543575 [TBL] [Abstract][Full Text] [Related]
50. Mechanism of neuropeptide Y inhibition of vasopressin action in rat cortical collecting tubule. Dillingham MA; Anderson RJ Am J Physiol; 1989 Mar; 256(3 Pt 2):F408-13. PubMed ID: 2538078 [TBL] [Abstract][Full Text] [Related]
51. Differential sensitivity of alpha o and alpha i to ADP-ribosylation by pertussis toxin in the intact cultured embryonic chick ventricular myocyte. Relationship to the role of G proteins in the coupling of muscarinic cholinergic receptors to inhibition of adenylate cyclase activity. Liang BT; Galper JB Biochem Pharmacol; 1988 Dec; 37(23):4549-55. PubMed ID: 3144283 [TBL] [Abstract][Full Text] [Related]
52. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms. Parker SL; Crowley WR Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069 [TBL] [Abstract][Full Text] [Related]
53. Anorexic action of a new potential neuropeptide Y antagonist [D-Tyr27,36, D-Thr32]-NPY (27-36) infused into the hypothalamus of the rat. Myers RD; Wooten MH; Ames CD; Nyce JW Brain Res Bull; 1995; 37(3):237-45. PubMed ID: 7627566 [TBL] [Abstract][Full Text] [Related]
54. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding? Iyengar S; Li DL; Simmons RM J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684 [TBL] [Abstract][Full Text] [Related]
55. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats. Bishop C; Parker GC; Coscina DV Psychopharmacology (Berl); 2002 Jul; 162(3):265-72. PubMed ID: 12122484 [TBL] [Abstract][Full Text] [Related]
56. Functional impairment of hypothalamic corticotropin-releasing factor neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y. Menzaghi F; Heinrichs SC; Pich EM; Tilders FJ; Koob GF Brain Res; 1993 Jul; 618(1):76-82. PubMed ID: 8402180 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. Pearson RD; Symes P; Conboy M; Weiss AA; Hewlett EL J Immunol; 1987 Oct; 139(8):2749-54. PubMed ID: 2888823 [TBL] [Abstract][Full Text] [Related]
58. Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hypothalamus. Sheriff S; Chance WT; Fischer JE; Balasubramaniam A Mol Pharmacol; 1997 Apr; 51(4):597-604. PubMed ID: 9106624 [TBL] [Abstract][Full Text] [Related]
59. Morphological evidence for direct interaction between arcuate nucleus neuropeptide Y (NPY) neurons and gonadotropin-releasing hormone neurons and the possible involvement of NPY Y1 receptors. Li C; Chen P; Smith MS Endocrinology; 1999 Nov; 140(11):5382-90. PubMed ID: 10537170 [TBL] [Abstract][Full Text] [Related]
60. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Pellieux C; Sauthier T; Domenighetti A; Marsh DJ; Palmiter RD; Brunner HR; Pedrazzini T Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1595-600. PubMed ID: 10660688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]